Pacertool is a Norwegian MedTech company founded in 2019 as a spin-off from the Oslo University Hospital. Based on more than 5 years of extensive research and clinical testing that resulted in the identification of a breakthrough cardiac biomarker and two novel measurement methods (3 patents), Pacertool has developed a disruptive hardware and software system – PaCRTool – that improves pacemaker implantation and the outcomes for patients with heart failure. Our concept is being supported by the likes of The Research Council of Norway, Innovation Norway, and the Eurostars Eureka Programme, private institutional investors and an experienced executive management team. The Pacertool team has a strong background in cardiology, medical device commercialization, medical image and signal processing, and hardware and software development.